<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32046039</article-id><article-id pub-id-type="pmc">7157590</article-id><article-id pub-id-type="doi">10.3390/vaccines8010074</article-id><article-id pub-id-type="publisher-id">vaccines-08-00074</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Assessment of Knowledge, Attitudes, and Propensity towards HPV Vaccine of Young Adult Students in Italy</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4633-202X</contrib-id><name><surname>Trucchi</surname><given-names>Cecilia</given-names></name><xref ref-type="aff" rid="af1-vaccines-08-00074">1</xref><xref ref-type="aff" rid="af2-vaccines-08-00074">2</xref><xref rid="c1-vaccines-08-00074" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9707-5214</contrib-id><name><surname>Amicizia</surname><given-names>Daniela</given-names></name><xref ref-type="aff" rid="af1-vaccines-08-00074">1</xref><xref ref-type="aff" rid="af2-vaccines-08-00074">2</xref><xref ref-type="aff" rid="af3-vaccines-08-00074">3</xref></contrib><contrib contrib-type="author"><name><surname>Tafuri</surname><given-names>Silvio</given-names></name><xref ref-type="aff" rid="af4-vaccines-08-00074">4</xref></contrib><contrib contrib-type="author"><name><surname>Sticchi</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="af2-vaccines-08-00074">2</xref><xref ref-type="aff" rid="af3-vaccines-08-00074">3</xref></contrib><contrib contrib-type="author"><name><surname>Durando</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="af2-vaccines-08-00074">2</xref><xref ref-type="aff" rid="af3-vaccines-08-00074">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3397-7331</contrib-id><name><surname>Costantino</surname><given-names>Claudio</given-names></name><xref ref-type="aff" rid="af5-vaccines-08-00074">5</xref></contrib><contrib contrib-type="author"><name><surname>Varlese</surname><given-names>Federica</given-names></name><xref ref-type="aff" rid="af1-vaccines-08-00074">1</xref></contrib><contrib contrib-type="author"><name><surname>Di Silverio</surname><given-names>Bruno</given-names></name><xref ref-type="aff" rid="af1-vaccines-08-00074">1</xref><xref ref-type="aff" rid="af2-vaccines-08-00074">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9079-8460</contrib-id><name><surname>Bagnasco</surname><given-names>Anna Maria</given-names></name><xref ref-type="aff" rid="af3-vaccines-08-00074">3</xref></contrib><contrib contrib-type="author"><name><surname>Ansaldi</surname><given-names>Filippo</given-names></name><xref ref-type="aff" rid="af1-vaccines-08-00074">1</xref><xref ref-type="aff" rid="af2-vaccines-08-00074">2</xref><xref ref-type="aff" rid="af3-vaccines-08-00074">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8463-8487</contrib-id><name><surname>Icardi</surname><given-names>Giancarlo</given-names></name><xref ref-type="aff" rid="af2-vaccines-08-00074">2</xref><xref ref-type="aff" rid="af3-vaccines-08-00074">3</xref></contrib></contrib-group><aff id="af1-vaccines-08-00074"><label>1</label>A.Li.Sa. Liguria Health Authority, 16121 Genoa, Italy; <email>daniela.amicizia@unige.it</email> (D.A.); <email>federica.varlese@regione.liguria.it</email> (F.V.); <email>bruno.disilverio@regione.liguria.it</email> (B.D.S.); <email>filippo.ansaldi@unige.it</email> (F.A.)</aff><aff id="af2-vaccines-08-00074"><label>2</label>IRCCS San Martino Hospital, 16132 Genoa, Italy; <email>sticchi@unige.it</email> (L.S.); <email>paolo.durando@unige.it</email> (P.D.); <email>icardi@unige.it</email> (G.I.)</aff><aff id="af3-vaccines-08-00074"><label>3</label>Department of Health Sciences, University of Genoa, 16132 Genoa, Italy; <email>annamaria.bagnasco@unige.it</email></aff><aff id="af4-vaccines-08-00074"><label>4</label>Policlinico General Hospital, 70124 Bari, Italy; <email>silvio.tafuri@uniba.it</email></aff><aff id="af5-vaccines-08-00074"><label>5</label>Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Excellence Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy; <email>claudio.costantino01@unipa.it</email></aff><author-notes><corresp id="c1-vaccines-08-00074"><label>*</label>Correspondence: <email>cecilia.trucchi@regione.liguria.it</email>; Tel.: +39-010-548-8218</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2020</year></pub-date><volume>8</volume><issue>1</issue><elocation-id>74</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background: Human Papillomavirus (HPV) is a common sexually transmitted infection (STI), representing the main cause of genital warts and cervical cancer. This cross-sectional study evaluated knowledge and attitudes about HPV infection, related diseases, and prevention and propensity towards HPV vaccine among undergraduate students. Methods: An online and written survey about HPV and its prevention, targeted to young adults of both genders, was addressed to students attending health sciences and other schools at Universities of Genoa and Bari. Results: The overall median knowledge and attitude scores were 56.3% (25&#x02013;75 <italic>p</italic> = 40&#x02013;68.8%) and four out of five (25&#x02013;75 <italic>p</italic> = 4&#x02013;5), respectively. In the multivariate analysis, attending a health sciences university, using social networks &#x02264;2 h a day, a history of STI, having heard about HPV and HPV vaccine previously resulted as predictors of higher knowledge scores. Having heard about HPV previously also predicted a high attitude score, together with a perceived economic status as good. Having Italian and healthcare worker parents, being employed, and following a specific diet, instead, predicted lower attitude score. Conclusions: Poor knowledge and good attitudes were found among undergraduates about HPV. In order to increase HPV vaccine compliance and the counselling skills of future healthcare workers, the improvement of training on HPV is needed.</p></abstract><kwd-group><kwd>HPV</kwd><kwd>knowledge</kwd><kwd>practice</kwd><kwd>attitude</kwd><kwd>young adults</kwd><kwd>vaccination</kwd><kwd>student</kwd><kwd>prevention</kwd><kwd>sexually transmitted infection</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-08-00074"><title>1. Introduction</title><p>Human papillomavirus (HPV) infection is recognized as the most common STI worldwide [<xref rid="B1-vaccines-08-00074" ref-type="bibr">1</xref>,<xref rid="B2-vaccines-08-00074" ref-type="bibr">2</xref>]. HPV infection is acquired soon after sexual debut, it is transient and cleared at an early age [<xref rid="B3-vaccines-08-00074" ref-type="bibr">3</xref>]. If persistent, it can lead to a wide range of benign lesions and cancers, affecting the ano-genital and the oropharyngeal tract in both sexes [<xref rid="B4-vaccines-08-00074" ref-type="bibr">4</xref>]. Of note, official epidemiological estimates report 570,000 cases and 311,000 deaths due to cervical cancer in 2018 worldwide, placing the disease as the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women [<xref rid="B5-vaccines-08-00074" ref-type="bibr">5</xref>]. The risk factors involved in the evolution of HPV-related diseases are the efficiency of the host&#x02019;s immune response and the characteristics of the virus, including the genotype, the presence of multiple HPV infections, the viral load and integration in the host genome [<xref rid="B6-vaccines-08-00074" ref-type="bibr">6</xref>]. Co-factors related to the development of ano-genital cancers are alcohol, smoking, and the presence of co-infections with other pathogens [<xref rid="B7-vaccines-08-00074" ref-type="bibr">7</xref>,<xref rid="B8-vaccines-08-00074" ref-type="bibr">8</xref>].</p><p>Data acquired in recent years confirm that HPV vaccines and screening are the most effective prevention tools [<xref rid="B9-vaccines-08-00074" ref-type="bibr">9</xref>]; in particular, solid evidence is accumulating about vaccine effectiveness, long-lasting protection, and economic benefits in the avoiding cases [<xref rid="B10-vaccines-08-00074" ref-type="bibr">10</xref>,<xref rid="B11-vaccines-08-00074" ref-type="bibr">11</xref>]. Indeed vaccination programs have been implemented in 74 countries all over the world (33 countries in the WHO European Region) targeting girls and 11 targeted to boys, achieving successful results [<xref rid="B12-vaccines-08-00074" ref-type="bibr">12</xref>]. In Italy, the HPV vaccine started in 2007, with a strategy of active call and free-of-charge vaccines targeting girls aged 11&#x02013;12 years [<xref rid="B13-vaccines-08-00074" ref-type="bibr">13</xref>]. Then the vaccination program was extended to males aged 11&#x02013;12 years and at-risk subjects (men who engage in same-sex sexual behaviors) [<xref rid="B14-vaccines-08-00074" ref-type="bibr">14</xref>,<xref rid="B15-vaccines-08-00074" ref-type="bibr">15</xref>] following the latest evidence about the cost-effectiveness of HPV vaccination in other targets [<xref rid="B16-vaccines-08-00074" ref-type="bibr">16</xref>]. Furthermore, women aged 25 years, at the moment of cervical cancer screening can benefit from the HPV vaccine, as recommended by the National Vaccine Plan 2017&#x02013;2019.</p><p>Despite this prevention opportunity, the coverage rate is still suboptimal in Italy, as in other countries, due to HPV vaccination uptake barriers, such as inadequate knowledge of HPV infection and related diseases, vaccination safety concerns, organizational aspects of HPV vaccine campaigns, and difficulties in vaccine schedule completion for subjects and providers [<xref rid="B17-vaccines-08-00074" ref-type="bibr">17</xref>]. In order to investigate the level of knowledge of HPV infection and vaccination, as well as the attitudes towards recommending the anti-HPV vaccine, an ad hoc knowledge and attitudes questionnaire was developed and administered to Italian young adult students.</p></sec><sec id="sec2-vaccines-08-00074"><title>2. Materials and Methods</title><sec id="sec2dot1-vaccines-08-00074" sec-type="subjects"><title>2.1. Study Design and Participants</title><p>A cross-sectional multicenter survey about HPV and its prevention, targeted to young adults of both genders, was carried out from May 2017 to December 2018. The study population included females who retain the right to free-charge vaccination, males who can benefit from the vaccine in co-payment regimens, and subjects at risk, like those who are HIV-positive and men who have sex with men. Recruitment of the study participants took place at the University of Genoa (Liguria region, Northwest Italy), University of Bari (Apulia region, Southern Italy), and the San Martino Hospital in Genoa. In particular, subjects were recruited among students attending healthcare profession schools (i.e., nurses and healthcare assistants) who are required to periodically undergo a medical examination at occupational health surveillance outpatient clinics and who are attending academic schools including public health and prevention subjects in the first and second academic years. The study staff enrolled the students at the outpatient clinic and on the occasion of academic lessons. The sample size was calculated considering the number of subjects belonging to the target study population, the at-risk subjects, and healthcare personnel, the available evidence about the HPV vaccine acceptability fixing the confidence interval at 95%, a margin of error (+/&#x02212;) of 2.5%, and adding a quota of 5%, in consideration of the possible drop-outs and missed answers.</p></sec><sec id="sec2dot2-vaccines-08-00074"><title>2.2. Data Collection and Questionnaire</title><p>Ad hoc anonymous questionnaires addressed to young adults were developed. They were self-administered using the Google Drive platform that automatically populates and saves digital responses into a secure Microsoft Excel database protecting participant confidentiality throughout the surveying process. A consent page reporting the study aims and objectives, the participant&#x02019;s right to the refusal or the possibility to terminate the participation in the study at any time and without disadvantages was created.</p><p>Participants could also fill two written informed consent and questionnaires characterized by the same structure of those administered online. The first questionnaire was set in two sections: the first one investigated the country of parent&#x02019;s birth, level of parent&#x02019;s education, parent&#x02019;s occupation, and, for the participant, demographics, level of education, occupation, economic status, professed religion, healthy behavior, such as following a specific nutritional regimen (diet) and sport practice, sexual behaviors and orientation, use of the Internet and social networks, the sources used for seeking information on sexually transmitted diseases (STDs), including HPV, and remembering about vaccines received during childhood. The first section also included a 10-point Likert scale ranking the interest to receive an HPV vaccine. The second section included 13 questions on the knowledge on HPV infection, related diseases, and vaccine. The second questionnaire assessed their attitude using nine statements with a five-point Likert scale for each one (5 points- Strongly Agree, 4 point-Agree, 3 points-Neutral, 2 points-Disagree, 1 points-Strongly Disagree). It also included a 10-point Likert scale on how much the participant was interested to receive HPV vaccine after reading some information on HPV infection, related diseases, and vaccine included at the beginning of the second questionnaire (self-learning). Based on the participants&#x02019; responses, the knowledge, attitude, and intention scores were calculated. The &#x02018;knowledge&#x02019; score summarizes the percentage of correct answers the participants gave among the knowledge questions. For each knowledge statement, one point was given for a correct answer (true or false) and zero points if they selected a wrong answer or &#x0201c;Do not know&#x0201d;. The total points were added for every participant and a percentage was calculated (number of correct answers/number of knowledge statements &#x000d7; 100). The higher the knowledge score, the more knowledgeable the participant is regarding HPV infection, its related diseases, and prevention. The attitude score was obtained by calculating the average of the participants&#x02019; responses to the statements on a five-point Likert scale. The median of the total points was calculated for every participant obtaining an attitude score ranging from 1.0 to 5.0. The closer the attitude score to 5, the more positive the participant&#x02019;s attitudes. The &#x0201c;intention&#x0201d; score reflects the propensity toward the HPV vaccine. The &#x0201c;intention&#x0201d; score was estimated both at the beginning and at the end of the survey, when the information about HPV infection and vaccination had been given. The score is a scale from 1 to 10, where 10 reflects the highest propensity toward the HPV vaccine.</p></sec><sec id="sec2dot3-vaccines-08-00074"><title>2.3. Statistical Analyses</title><p>Statistical analysis was performed by means of JMP software (SAS, NC), version 13 and Microsoft Excel, version 2016 after generating data from the written questionnaires and Google Drive (CA, USA). Median and 25&#x02013;75 percentiles for continuous variables, frequencies, and percentages for categorical variables were calculated. The possible association of baseline characteristics of young adults with knowledge and attitude scores was tested through univariable logistic regression. A <italic>p</italic>-value less than 0.05 was considered significant throughout the study. Multivariate logistic regression analysis was performed to identify the predictors of having high knowledge score or positive attitude score towards HPV vaccination. Only covariates that showed a significance level of <italic>p</italic>-value &#x0003c; 0.1 in the univariate analysis were included in the multivariable regression model, using a backward stepwise algorithm. Given the high number of potential independent variables, a backward stepwise algorithm was used to identify the best-fitting subset of variables to use in the final regression model. In particular, Akaike&#x02019;s Information Criterion (AIC) was used to assess the models&#x02019; fit and the model with the lowest AIC was selected for the multivariable analysis. &#x003b2;-coefficients (95% C.I.) and <italic>p</italic>-values were estimated.</p></sec><sec id="sec2dot4-vaccines-08-00074"><title>2.4. Ethics Approval and Consent to Participate</title><p>In complying with the highest ethical standards, participants were informed that their participation was entirely voluntary and that they could withdraw at any moment. All data obtained through their participation was kept strictly confidential among the research team. In addition, an informed consent was obtained after explaining the nature of the study and its possible consequences of it. The study protocol was approved by the Liguria Regional Ethics Committee (P.R. 162REG2017) for the study coordination center.</p></sec></sec><sec sec-type="results" id="sec3-vaccines-08-00074"><title>3. Results</title><sec id="sec3dot1-vaccines-08-00074" sec-type="subjects"><title>3.1. Participants&#x02019; Characteristics</title><p>A total of 680 young adults returned the self-administered questionnaires, giving a response rate of 100%. <xref rid="vaccines-08-00074-t001" ref-type="table">Table 1</xref> shows the participants&#x02019; baseline characteristics. The median age of the participants was 20 (25&#x02013;75 <italic>p</italic> = 19&#x02013;21), 65.2% were female and 95.9% were Italian. A total of 97.1% declared to be students and only 2.9% were employed. A total of 24.5% of subjects had a graduate parent and 10.4% had at least one parent who was a health care operator. A total of 53.3% of the subjects consider their own economic status as good. As regards lifestyle habits, 23.1% and 56.6% of participants follow a specific diet and practice sports, respectively. Furthermore, 65% and 49.6% of young adults surfed the Internet and used the social networks up to 2 h a day, respectively. Among sexual habits, 61.8% of subjects had a partner at the time of the survey and 83.8% used contraceptive methods, the most reported of which was condom use (61.7% of cases). Furthermore, 97.2% of participants were heterosexual. The median age of sexual debut and number of partners in the last year were 17 (25&#x02013;75 <italic>p</italic> = 16&#x02013;18) and 1 (25&#x02013;75 <italic>p</italic> = 1&#x02013;1), respectively.</p></sec><sec id="sec3dot2-vaccines-08-00074"><title>3.2. Sources of Information about HPV</title><p>A total of 80.4% of subjects had heard about HPV vaccine before the survey, in particular from a family member (43.7% of cases), Internet (24% of cases), teachers (25.1% of cases), and LHAs informative material (23.6% of cases) (<xref rid="vaccines-08-00074-t002" ref-type="table">Table 2</xref>).</p></sec><sec id="sec3dot3-vaccines-08-00074"><title>3.3. Knowledge of HPV Infection, Related Diseases, and Prevention</title><p>The overall median knowledge score was 56.3% (25&#x02013;75 <italic>p</italic> = 40&#x02013;68.8).</p><p>Most of the subjects answered correctly the statement that HPV is sexually transmitted (82.4%) and that using condoms reduces the risk of HPV infection (86.2%) (<xref rid="vaccines-08-00074-t003" ref-type="table">Table 3</xref>). Only 40.3% knew that HPV infection can be transmitted during pregnancy and delivery from mother to the child. Among risk factors of exposure to HPV infection, only about 50% of participants recognized the early sexual debut. A total of 77.5% of the subjects knew that HPV infects both females and males, but only 21.4% and 54% correlates HPV to penile and cervical cancers, respectively. In terms of benign diseases, the information that HPV can cause genital warts is known by 42.8% of subjects, and 80.4% are aware that both females and males can develop them. Only 52.7% and 48.7% of subjects are aware that HPV infection is widespread and can be transmitted by asymptomatic carriers. Furthermore, 40.9% of participants think that most infected subjects develop cancer. As regards HPV therapy, only 23.4% of participants knew that no specific treatments are available. Finally, 67.8% and 58.8% of young adults correctly answered the questions related to the indication of HPV vaccine targeting both females and males and the efficacy of HPV vaccine in adults who already had a sexual debut.</p><p><xref rid="vaccines-08-00074-t004" ref-type="table">Table 4</xref> shows the results of univariable logistic regression investigating the possible association between the characteristics of the participant young adults and the knowledge score. Variables significantly related to higher knowledge scores are: attending a healthcare university (<italic>p</italic> &#x0003c; 0.0001), using social networks up to 2 h a day (<italic>p</italic> = 0.0215), history of sexual transmitted infection and of HPV-related lesions (<italic>p</italic> = 0.0349 and <italic>p</italic> = 0.0290, respectively), and having heard about HPV before the survey (<italic>p</italic> = 0.0035). Furthermore, family members and mass media as source of information about HPV are significantly related to worse knowledge scores (<italic>p</italic> = 0.0501 and <italic>p</italic> = 0.0762, respectively). Gynecologists, instead, are reported as a source of information by young adults with significantly higher knowledge scores (<italic>p</italic> = 0.0014).</p></sec><sec id="sec3dot4-vaccines-08-00074"><title>3.4. Attitudes about HPV Infection and Prevention</title><p>The overall median attitude score was as high as 4 (25&#x02013;75 <italic>p</italic> = 4&#x02013;5). Only 49.7% of participants agree or strongly agree that during the own life he/she will have high probability to be exposed to HPV infections (<xref rid="vaccines-08-00074-t005" ref-type="table">Table 5</xref>). A total of 93.8% of subjects, instead, are aware that HPV can cause serious diseases. As regards the favorite source of information and opinion to get vaccinated, the most reported were trusted doctors (85.3%) and teachers (90.4%), followed by parents and partners (51.8% and 39.9%, respectively). About safety concern, 76.5% of partipants believe that HPV vaccine is safe. Furthermore, 83.5% agree or strongly agree to have their own child vaccinated.</p><p><xref rid="vaccines-08-00074-t004" ref-type="table">Table 4</xref> shows the results of univariable logistic regression investigating the possible association between the characteristics of the participant young adults and the attitude score. Significantly higher attitude scores were reported among subjects with foreign parents, without parents who are healthcare workers (<italic>p</italic> = 0.0103), who are not employed (<italic>p</italic> = 0.0211), who reported a good economic status (<italic>p</italic> = 0.0031), who do not follow a specific diet (<italic>p</italic> = 0.0004), who use social network up to 2 h a day (<italic>p</italic> = 0.0115), those without immunodeficiencies (<italic>p</italic> = 0.0381), and those who heard about HPV before the survey (<italic>p</italic> &#x0003c; 0.0001). As regards the source of information about HPV vaccine, subjects who reported teachers, LHAs informative material, pediatricians/general practitioners, had significantly higher attitude scores (<italic>p</italic> = 0.0100, <italic>p</italic> = 0.0081, and <italic>p</italic> = 0.0061, respectively).</p></sec><sec id="sec3dot5-vaccines-08-00074"><title>3.5. Propensity toward HPV Vaccination</title><p>The median propensity score before and after the educational intervention was stable and high as 9 (25&#x02013;75 <italic>p</italic> = 8&#x02013;10).</p></sec><sec id="sec3dot6-vaccines-08-00074"><title>3.6. Multivariate Analysis</title><p>The results of the multivariate analysis predicting high knowledge and attitude scores are presented in <xref rid="vaccines-08-00074-t006" ref-type="table">Table 6</xref> and <xref rid="vaccines-08-00074-t007" ref-type="table">Table 7</xref>, respectively. The predictors of high knowledge are attending Healthcare University, using social network &#x02264;2 h/day, having a history of STIs, and having heard about HPV and anti-HPV vaccine before the survey. As regards predictors of high attitude score, a good economic status and having heard about HPV before the survey are predicted to have more positive attitudes towards HPV vaccine, while having Italian parents, being employed, and a parent who is/was a healthcare worker are predicted to have worse attitudes. Both the models significantly help in predicting knowledge and attitude scores since the <italic>p</italic>-values of the <italic>F</italic>-test are &#x0003c;0.0001.</p></sec></sec><sec sec-type="discussion" id="sec4-vaccines-08-00074"><title>4. Discussion</title><p>To the best of our knowledge, this is one of the first studies to quantitatively investigate knowledge and attitudes about HPV, and propensity towards HPV vaccination before and after a formative moment, in young adults students of both genders living in a high gross domestic product (GDP) country such as Italy, where a dynamicity in the objectives and targets of HPV vaccination by public health since its introduction in 2007 was observed. This study was performed not only in undergraduates attending health sciences schools, but also in other university students.</p><p>Young adults are a category at risk of sexually transmitted HPV infection. Since HPV has a causative role in serious and frequent diseases, such as cancers and genital warts, respectively, interventions to prevent low and high-risk types of HPV infections are urgently warranted; indeed, vaccinating both men and women against HPV is crucial to protect against HPV-related cancers and other diseases.</p><p>Recent international recommendation on HPV vaccination have included additional age classes, not only adolescents of both genders (aged 11&#x02013;12 years), but also females 13&#x02013;26 years-old who have not been previously vaccinated or who have not completed the vaccine series, and males aged 13&#x02013;21 years and 22&#x02013;26 years with special conditions or who want to protect themselves from the disease [<xref rid="B17-vaccines-08-00074" ref-type="bibr">17</xref>,<xref rid="B18-vaccines-08-00074" ref-type="bibr">18</xref>]. The current Italian National Vaccine Prevention Plan (NVPP) 2017&#x02013;2019 extended the vaccination program to include pre-adolescent males (aged between 11 and 12 years) and at-risk subjects (men who engage in same-sex sexual behaviors) [<xref rid="B14-vaccines-08-00074" ref-type="bibr">14</xref>]. Furthermore, the NVPP recommends a multi-cohort immunization strategy, preferably targeting 25 years-old young adult females who begin cervical cancer screening. Based on the current vaccination plans and the need to implement knowledge and attitude of young adults of both gender, an overall approach is desired. Indeed, it is of note that HPV coverage rates are suboptimal in both genders in many developed countries, including Italy [<xref rid="B19-vaccines-08-00074" ref-type="bibr">19</xref>].</p><p>An evaluation of what young adults know about the threat of HPV and believe about HPV prevention can offer possible solutions to remedy the underutilization of the HPV vaccine in a population at high risk for contracting this preventable infection and to explore innovative strategies. The findings are, therefore, relevant at the light of better understanding and comparing educational needs and attitudes toward HPV infection and prevention in one of the HPV vaccine targets [<xref rid="B20-vaccines-08-00074" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-08-00074" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-08-00074" ref-type="bibr">22</xref>]. Furthermore, the interviewed subset including health sciences students, allowed estimating knowledge needs and main attitudes of future healthcare workers and counsellors.</p><p>Our findings highlight, on one side, insufficient knowledge of undergraduate students on HPV infection and HPV- related diseases, on the other side, a substantial positive attitude toward the vaccine. Gaps on HPV knowledge were detected in previous studies enrolling study population similar to our study population for demographic characteristics [<xref rid="B23-vaccines-08-00074" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-08-00074" ref-type="bibr">24</xref>,<xref rid="B25-vaccines-08-00074" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-08-00074" ref-type="bibr">26</xref>]. In our survey, a not negligible percentage of students had low consciousness about the impact of HPV infection in terms of spread, the routes of infection, and risk factors, such as early sexual debut, the role of HPV in causing penile cancer and genital warts, and the unavailability of specific therapeutic treatment. This would confirm the need to promote educational programs for young subjects and introducing changes in the current curriculum of university students attending health sciences schools, in order to increase understanding about HPV of future healthcare professionals. However, as expected, higher knowledge was detected in health sciences students&#x02019; respect to undergraduates attending other academic course (<italic>p</italic> &#x0003c; 0.0001). Results worthy of highlighting are that more than 93% affirmed that HPV can be implicated in developing serious disease but only 49.7% consider themselves at risk of exposure to HPV. These results are comparable with those described by Villanueva et al. who recently investigated knowledge, attitudes, and intentions towards HPV among nursing students in Spain [<xref rid="B25-vaccines-08-00074" ref-type="bibr">25</xref>]. As regards attitudes towards HPV vaccine, more than 90% and 76% of participants consider HPV vaccine effective and safe, respectively. In a very recent Italian cross-sectional study that assessed nursing students&#x02019; knowledge and attitudes about HPV infection and vaccination, only 20.5% of subjects considered very safe the HPV vaccine [<xref rid="B27-vaccines-08-00074" ref-type="bibr">27</xref>]. The abovementioned Spanish study also investigated attitudes towards HPV vaccine efficacy and safety, finding that 66.5% and 65.4% of students agree or strongly agree that HPV is capable of preventing the occurrence of cervical cancer and that side effects are reasonable, respectively [<xref rid="B25-vaccines-08-00074" ref-type="bibr">25</xref>]. We also investigated the willingness of participants considered as potential future parents to get their own child immunized against HPV and only 83.5% agree or strongly agree with this sentence. This observation is of concern since it demonstrates that the high consciousness of the causal role of HPV in determining serious diseases, such as cancers, is not a sufficient factor in determining recommended vaccine compliance.</p><p>Among young adults characteristics, parents&#x02019; nationality, educational qualification, and employment were investigated in relation to knowledge and attitude scores. The knowledge score resulted higher, although not statistically significant, in young adults with healthcare worker parents, while the attitude score was higher for subjects with parents who are employed in other sectors. This observation could be linked to the well-known largely suboptimal compliance of healthcare workers to vaccines [<xref rid="B28-vaccines-08-00074" ref-type="bibr">28</xref>,<xref rid="B29-vaccines-08-00074" ref-type="bibr">29</xref>]. Furthermore, considering the parents&#x02019; nationality, knowledge scores of young subjects was similar between those with Italian parents and those without. On the contrary, the attitude score was higher in those with foreigner parents (<italic>p</italic> = 0.0491), who mainly come from developing countries. A possible explanation could be a better propensity by the foreign families towards Italian healthcare services, including prevention. As regards lifestyles, the young who follow specific nutritional regimen had significantly lower attitude score (<italic>p</italic> = 0.0044), confirmed by multivariate analysis (<italic>p</italic> &#x0003c; 0.0001), this could be explained by the fact that those who engage in specific behaviors oriented around &#x02018;the natural&#x02019; is often hesitant or refuse vaccines [<xref rid="B30-vaccines-08-00074" ref-type="bibr">30</xref>]. Surprisingly, physical activity was related neither to higher knowledge nor to attitude scores. Although healthy lifestyles are expected to be related to better compliance to preventive measures. Among sexual habits, 83.8% of subjects who had a partner at the time of the survey (61.8% of participating young adults) used contraceptive methods, the most represented of which was condom use (61.7%), followed by oral contraceptive (31.8%). Furthermore, the median age of sexual debut was 17 (25&#x02013;75 <italic>p</italic> = 16&#x02013;18), with a median of lifetime sexual partners of 2 (25&#x02013;75 <italic>p</italic> = 1&#x02013;4). These findings are substantially comparable with the observations obtained in other European countries [<xref rid="B22-vaccines-08-00074" ref-type="bibr">22</xref>,<xref rid="B25-vaccines-08-00074" ref-type="bibr">25</xref>]. Considering sexual orientation, 1.3% and 1.5% were bisexual and homosexual, respectively. Of relevance, homosexual surveyed subjects demonstrated higher knowledge than heterosexual and bisexual subjects, although this result has to be interpreted with caution because of the scarce number of surveyed homosexual and bisexual subjects. A possible explanation could be the higher attention toward to health and prevention tools by homosexuals. History of STIs and HPV-related lesions was also investigated, showing that only 4.9% and 2.2% of subjects were diagnosed for the abovementioned diseases, respectively. Furthermore, the history of STIs was found as predictor of high knowledge score at the multivariate analysis (<italic>p</italic> = 0.0440). This observation could be linked to the previous contact of affected subjects with the healthcare system which could have favored the acquisition of knowledge on this topic.</p><p>Before the educational moment, subjects were asked to declare if they have heard about HPV previously. Our findings revealed that a high percentage of young (80%) already knew this infection, which is well up rates reported in other published research [<xref rid="B31-vaccines-08-00074" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-08-00074" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-08-00074" ref-type="bibr">33</xref>] and significantly predicts both higher knowledge and attitude scores (<italic>p</italic> = 0.0072 and <italic>p</italic> &#x0003c; 0.001). In particular, family members, Internet, teachers, and LHAs&#x02019; informative material were the most frequently reported sources of information. Surfing the web and the use of social networks were also investigated, showing that using social network &#x02264;2 h/day is among the predictors of better knowledge on HPV compared to higher use (<italic>p</italic> = 0.0141). This finding suggests that social networks can also disseminate misleading messages on HPV. Nevertheless, the increasing pervasiveness of social media, such as Facebook, as powerful communication channels means that they can potentially be used to effectively reach young people. Therefore, public health should better communicate messages through existing networks and engage in on-going dialogue with users [<xref rid="B34-vaccines-08-00074" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-08-00074" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-08-00074" ref-type="bibr">36</xref>].</p><p>Our study also deepened attitudes regarding the favorite sources of information about HPV of participating subjects, finding that talking about HPV with teachers and trusted doctor is considered very useful by young adults, while only 51.8% and 39.9% of participants believe that parents&#x02019; and partner&#x02019;s opinions are essential to decide to get vaccinated against HPV. These answers confirm the role of physicians and teachers recognized by young adults in spreading health information including sensitive topics such as STIs. Of note, the majority of participants (83.92%) agree or strongly agree to make compulsory HPV vaccine for boys and girls before the sexual debut and for at risk subjects. This is of interest in countries such as Italy where a recent law introduced the compulsory of some vaccines, excluding HPV [<xref rid="B37-vaccines-08-00074" ref-type="bibr">37</xref>].</p><p>In order to evaluate the efficacy of educational intervention in implementing the propensity of young adults toward HPV vaccine, we estimated it through a score before and after the administration of a written text summarizing the available evidences on HPV infection, related diseases and prevention. The score resulted very high (median = 9, 25&#x02013;75 <italic>p</italic> = 8&#x02013;10) and remained stable after the educational session. A recent meta-analysis that assessed the effectiveness of interventions targeting HPV vaccine initiation and completion among children, adolescents, and young adults aged 9&#x02013;26 years support behavioral and informational interventions, including education (e.g., exercises, audit and feedback, video intervention, peer/medical narrative), educational websites tailored to baseline knowledge, and brochures/factsheets, for HPV vaccine initiation and behavioral interventions for completion [<xref rid="B38-vaccines-08-00074" ref-type="bibr">38</xref>]. Considering the surveyed subset of health sciences students, and their future role in counselling on prevention themes, a comparison with the results of a recent published study by Berenson et al. could be conducted. The authors assessed the effects of an educational program by means of a single lecture and delivered by an expert and found that this can improve medical students&#x02019; attitudes and comfort with HPV vaccine counseling [<xref rid="B39-vaccines-08-00074" ref-type="bibr">39</xref>]. This evidence suggests that short educational interventions are already efficacious, but the presence of an expert open to discussion allows obtaining better results than reading informative material alone.</p><p>The study limits are the nature of self-reported data collected from the participants, which may be compromised by the respondents&#x02019; memory of experiences of interest. Furthermore, since northern and southern regions were involved in the enrollments, the representativeness of young adults living in the Central Italian regions is lacking. Despite these limitations, this survey obtained a very high response rate, demonstrating the strong interest in HPV topic. As regards education, the self-learning session could be improved by focus groups and other interactive methods. Nevertheless, academic public health teaching includes HPV burden and prevention among treated themes.</p></sec><sec sec-type="conclusions" id="sec5-vaccines-08-00074"><title>5. Conclusions</title><p>The results of the current study demonstrates that Italian undergraduates show suboptimal knowledge on HPV and good attitudes. Since they represent both the target of HPV vaccine and future healthcare workers, the implementation of training about HPV infection, its related diseases, and prevention tools are needed to support the important role they play in the prevention of STIs, some of which are related to the occurrence of cancer. Universities represent a privileged setting to spread information about HPV to the target audience and young adults recognize teachers together with trusted doctors as the favorite source of information. Improving students&#x02019; knowledge may have favorable implications in increasing vaccine coverage rates.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank the students attending Universities of Genoa and Bari for their participation in the study.</p></ack><notes><title>Author Contributions</title><p>Conceptualization:, C.T. and G.I.; Methodology: C.T. and F.A.; Formal analysis: C.T.; Investigation: S.T., L.S., P.D. and A.M.B.; Resources: S.T., L.S., P.D. and A.M.B.; Data curation: C.T., F.V. and B.D.S.; Writing&#x02014;Original draft preparation: C.T. and C.C.; Writing&#x02014;Review and editing: C.T., F.A., G.I and D.A.; Supervision: F.A. and G.I.; Project administration: C.T. and G.I. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>The research was conducted with the support of Sanofi Pasteur MSD, who funded a fixed-term contract for an assistant professor in public health. The funding sources neither influenced the design of the study nor the analysis of the results.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>Giancarlo Icardi is the principal investigator of this national multicenter study. The research staff included the fixed-term assistant professor funded by Sanofi Pasteur MSD. The other authors have no known competing financial interests nor personal relationships that could have appeared to influence the work reported in this paper. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-08-00074"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satterwhite</surname><given-names>C.L.</given-names></name><name><surname>Torrone</surname><given-names>E.</given-names></name><name><surname>Meites</surname><given-names>E.</given-names></name><name><surname>Dunne</surname><given-names>E.F.</given-names></name><name><surname>Mahajan</surname><given-names>R.</given-names></name><name><surname>Ocfemia</surname><given-names>M.C.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Weinstock</surname><given-names>H.</given-names></name></person-group><article-title>Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008</article-title><source>Sex. Transm. Dis.</source><year>2013</year><volume>40</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1097/OLQ.0b013e318286bb53</pub-id><pub-id pub-id-type="pmid">23403598</pub-id></element-citation></ref><ref id="B2-vaccines-08-00074"><label>2.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Human Papillomavirus (HPV) and Cervical Cancer</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer">https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer </ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-20">(accessed on 20 October 2019)</date-in-citation></element-citation></ref><ref id="B3-vaccines-08-00074"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>F.X.</given-names></name><name><surname>de Sanjos&#x000e9;</surname><given-names>S.</given-names></name></person-group><article-title>Chapter 1: Human papillomavirus and cervical cancer&#x02014;burden and assessment of causality</article-title><source>J. Natl. Cancer Inst. Monogr.</source><year>2003</year><volume>31</volume><fpage>3</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.jncimonographs.a003479</pub-id><pub-id pub-id-type="pmid">12807939</pub-id></element-citation></ref><ref id="B4-vaccines-08-00074"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>B.</given-names></name><name><surname>Brotons</surname><given-names>M.</given-names></name><name><surname>Bosch</surname><given-names>F.X.</given-names></name><name><surname>Bruni</surname><given-names>L.</given-names></name></person-group><article-title>Epidemiology and burden of HPV-related disease</article-title><source>Best Pract. Res. Clin. Obstet. Gynaecol.</source><year>2018</year><volume>47</volume><fpage>14</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.bpobgyn.2017.08.006</pub-id><pub-id pub-id-type="pmid">29037457</pub-id></element-citation></ref><ref id="B5-vaccines-08-00074"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Siegel</surname><given-names>R.L.</given-names></name><name><surname>Torre</surname><given-names>L.A.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J. Clin.</source><year>2018</year><volume>68</volume><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.3322/caac.21492</pub-id><pub-id pub-id-type="pmid">30207593</pub-id></element-citation></ref><ref id="B6-vaccines-08-00074"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiffman</surname><given-names>M.</given-names></name><name><surname>Kjaer</surname><given-names>S.K.</given-names></name></person-group><article-title>Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia</article-title><source>J. Natl. Cancer Inst. Monogr.</source><year>2003</year><volume>31</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.jncimonographs.a003476</pub-id><pub-id pub-id-type="pmid">12807940</pub-id></element-citation></ref><ref id="B7-vaccines-08-00074"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkelestein</surname><given-names>W.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Smoking and cancer of the uterine cervix: Hypotesis</article-title><source>Am. J. Epidemiol.</source><year>1977</year><volume>106</volume><fpage>257</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a112460</pub-id><pub-id pub-id-type="pmid">910793</pub-id></element-citation></ref><ref id="B8-vaccines-08-00074"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokopczyk</surname><given-names>B.</given-names></name><name><surname>Cox</surname><given-names>J.E.</given-names></name><name><surname>Hoffmann</surname><given-names>D.</given-names></name><name><surname>Waggoner</surname><given-names>S.E.</given-names></name></person-group><article-title>Identification of tobacco specific carcinogen in the cervical mucus of smokers and nonsmokers</article-title><source>J. Natl. Cancer Inst.</source><year>1997</year><volume>89</volume><fpage>868</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1093/jnci/89.12.868</pub-id><pub-id pub-id-type="pmid">9196253</pub-id></element-citation></ref><ref id="B9-vaccines-08-00074"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brotherton</surname><given-names>J.M.L.</given-names></name></person-group><article-title>Impact of HPV vaccination: Achievements and future challenges</article-title><source>Papillomavirus Res.</source><year>2019</year><volume>7</volume><fpage>138</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.pvr.2019.04.004</pub-id><pub-id pub-id-type="pmid">30978413</pub-id></element-citation></ref><ref id="B10-vaccines-08-00074"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>A.</given-names></name></person-group><article-title>HPV Vaccination and Testing</article-title><source>Rev. Obstet. Gynecol.</source><year>2010</year><volume>3</volume><fpage>33</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">20508781</pub-id></element-citation></ref><ref id="B11-vaccines-08-00074"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prue</surname><given-names>G.</given-names></name><name><surname>Baker</surname><given-names>P.</given-names></name><name><surname>Graham</surname><given-names>D.</given-names></name><name><surname>Nutting</surname><given-names>C.</given-names></name><name><surname>Greenhouse</surname><given-names>P.</given-names></name><name><surname>Lawler</surname><given-names>M.</given-names></name></person-group><article-title>It is time for universal HPV vaccination</article-title><source>Lancet</source><year>2018</year><volume>392</volume><fpage>913</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)31821-X</pub-id></element-citation></ref><ref id="B12-vaccines-08-00074"><label>12.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Regional Office for Europe</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.euro.who.int/__data/assets/pdf_file/0010/356842/QA_HPV_General_EN.pdf">http://www.euro.who.int/__data/assets/pdf_file/0010/356842/QA_HPV_General_EN.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-20">(accessed on 20 October 2019)</date-in-citation></element-citation></ref><ref id="B13-vaccines-08-00074"><label>13.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>Ministero Della Salute</collab></person-group><article-title>Campagna di Comunicazione Contro il Papilloma Virus-2008</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.salute.gov.it/portale/news/p3_2_6_1_1.jsp?lingua=italiano&#x00026;menu=campagne&#x00026;p=dacampagne&#x00026;id=42">http://www.salute.gov.it/portale/news/p3_2_6_1_1.jsp?lingua=italiano&#x00026;menu=campagne&#x00026;p=dacampagne&#x00026;id=42</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-20">(accessed on 20 October 2019)</date-in-citation></element-citation></ref><ref id="B14-vaccines-08-00074"><label>14.</label><element-citation publication-type="gov"><article-title>Intesa tra il Governo, le Regioni e le Province Autonome di Trento e Bolzano sul Documento recante &#x0201c;Piano Nazionale Prevenzione Vaccinale (PNPV) 2017&#x02013;2019&#x0201d;. Intesa ai Sensi Dell&#x02019;Articolo 8, Comma 6, Della Legge 5 Giugno. 2003, n. 131</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf">http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-20">(accessed on 20 October 2019)</date-in-citation></element-citation></ref><ref id="B15-vaccines-08-00074"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soe</surname><given-names>N.N.</given-names></name><name><surname>Ong</surname><given-names>J.J.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Fairley</surname><given-names>C.K.</given-names></name><name><surname>Latt</surname><given-names>P.M.</given-names></name><name><surname>Jing</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness</article-title><source>Hum. Vaccine Immunother.</source><year>2018</year><volume>14</volume><fpage>3010</fpage><lpage>3018</lpage><pub-id pub-id-type="doi">10.1080/21645515.2018.1496878</pub-id><pub-id pub-id-type="pmid">30024823</pub-id></element-citation></ref><ref id="B16-vaccines-08-00074"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>S.S.</given-names></name><name><surname>Hutubessy</surname><given-names>R.</given-names></name><name><surname>Chaiyakunapruk</surname><given-names>N.</given-names></name></person-group><article-title>Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination</article-title><source>Vaccine</source><year>2018</year><volume>36</volume><fpage>2529</fpage><lpage>2544</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2018.03.024</pub-id><pub-id pub-id-type="pmid">29625764</pub-id></element-citation></ref><ref id="B17-vaccines-08-00074"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.K.</given-names></name><name><surname>Hunter</surname><given-names>P.</given-names></name><collab>Advisory Committee on Immunization Practices</collab></person-group><article-title>Recommended Adult Immunization Schedule, United States, 2019</article-title><source>Ann. Intern. Med.</source><year>2019</year><volume>170</volume><fpage>182</fpage><pub-id pub-id-type="doi">10.7326/M18-3600</pub-id><pub-id pub-id-type="pmid">30716757</pub-id></element-citation></ref><ref id="B18-vaccines-08-00074"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saslow</surname><given-names>D.</given-names></name><name><surname>Andrews</surname><given-names>K.S.</given-names></name><name><surname>Manassaram-Baptiste</surname><given-names>D.</given-names></name><name><surname>Loomer</surname><given-names>L.</given-names></name><name><surname>Lam</surname><given-names>K.E.</given-names></name><name><surname>Fisher-Borne</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>R.A.</given-names></name><name><surname>Fontham</surname><given-names>E.T.</given-names></name><collab>American Cancer Society Guideline Development Group</collab></person-group><article-title>Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement</article-title><source>CA Cancer J. Clin.</source><year>2016</year><volume>66</volume><fpage>375</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.3322/caac.21355</pub-id><pub-id pub-id-type="pmid">27434803</pub-id></element-citation></ref><ref id="B19-vaccines-08-00074"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trucchi</surname><given-names>C.</given-names></name><name><surname>Costantino</surname><given-names>C.</given-names></name><name><surname>Restivo</surname><given-names>V.</given-names></name><name><surname>Bertoncello</surname><given-names>C.</given-names></name><name><surname>Fortunato</surname><given-names>F.</given-names></name><name><surname>Tafuri</surname><given-names>S.</given-names></name><name><surname>Amicizia</surname><given-names>D.</given-names></name><name><surname>Martinelli</surname><given-names>D.</given-names></name><name><surname>Paganino</surname><given-names>C.</given-names></name><name><surname>Piazza</surname><given-names>M.F.</given-names></name><etal/></person-group><article-title>Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives</article-title><source>Biomed Res. Int.</source><year>2019</year><volume>4</volume><fpage>6764154</fpage><pub-id pub-id-type="doi">10.1155/2019/6764154</pub-id><pub-id pub-id-type="pmid">31355274</pub-id></element-citation></ref><ref id="B20-vaccines-08-00074"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>R.</given-names></name><name><surname>McNutt</surname><given-names>L.A.</given-names></name><name><surname>Mehta</surname><given-names>M.</given-names></name><name><surname>Salmon</surname><given-names>D.A.</given-names></name><name><surname>Bednarczyk</surname><given-names>R.A.</given-names></name><name><surname>Shaw</surname><given-names>J.</given-names></name></person-group><article-title>Vaccination perspectives among adolescents and their desired role in the decision-making process</article-title><source>Hum. Vaccine Immunother.</source><year>2019</year><volume>15</volume><fpage>1752</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1080/21645515.2019.1571891</pub-id></element-citation></ref><ref id="B21-vaccines-08-00074"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caskey</surname><given-names>R.</given-names></name><name><surname>Lindau</surname><given-names>S.T.</given-names></name><name><surname>Alexander</surname><given-names>G.C.</given-names></name></person-group><article-title>Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey</article-title><source>J. Adolesc. Health</source><year>2009</year><volume>45</volume><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/j.jadohealth.2009.04.021</pub-id><pub-id pub-id-type="pmid">19837351</pub-id></element-citation></ref><ref id="B22-vaccines-08-00074"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeannot</surname><given-names>E.</given-names></name><name><surname>Viviano</surname><given-names>M.</given-names></name><name><surname>Follonier</surname><given-names>M.C.</given-names></name><name><surname>Kaech</surname><given-names>C.</given-names></name><name><surname>Oberhauser</surname><given-names>N.</given-names></name><name><surname>Mpinga</surname><given-names>E.K.</given-names></name><name><surname>Vassilakos</surname><given-names>P.</given-names></name><name><surname>Kaiser</surname><given-names>B.</given-names></name><name><surname>Petignat</surname><given-names>P.</given-names></name></person-group><article-title>Human Papillomavirus Infection and Vaccination: Knowledge, Attitude and Perception among Undergraduate Men and Women Healthcare University Students in Switzerland</article-title><source>Vaccines</source><year>2019</year><volume>7</volume><elocation-id>130</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines7040130</pub-id></element-citation></ref><ref id="B23-vaccines-08-00074"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topan</surname><given-names>A.</given-names></name><name><surname>Ozturk</surname><given-names>O.</given-names></name><name><surname>Eroglu</surname><given-names>H.</given-names></name><name><surname>Bahadir</surname><given-names>O.</given-names></name><name><surname>Harma</surname><given-names>M.</given-names></name><name><surname>Harma</surname><given-names>M.I.</given-names></name></person-group><article-title>Knowledge level of working and student nurses on cervical cancer and human papilloma virus vaccines. Asian Pac</article-title><source>J. Cancer Prev.</source><year>2015</year><volume>16</volume><fpage>2515</fpage><lpage>2519</lpage></element-citation></ref><ref id="B24-vaccines-08-00074"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzunlar</surname><given-names>&#x000d6;.</given-names></name><name><surname>&#x000d6;zyer</surname><given-names>&#x0015e;.</given-names></name><name><surname>Ba&#x0015f;er</surname><given-names>E.</given-names></name><name><surname>To&#x0011f;rul</surname><given-names>C.</given-names></name><name><surname>Karaca</surname><given-names>M.</given-names></name><name><surname>G&#x000fc;ng&#x000f6;r</surname><given-names>T.</given-names></name></person-group><article-title>A survey on human papillomavirus awareness and acceptance of vaccination among nursing students in a tertiary hospital in Ankara, Turkey</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>2191</fpage><lpage>2195</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2013.01.033</pub-id><pub-id pub-id-type="pmid">23375980</pub-id></element-citation></ref><ref id="B25-vaccines-08-00074"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villanueva</surname><given-names>S.</given-names></name><name><surname>Mosteiro-Migu&#x000e9;ns</surname><given-names>D.G.</given-names></name><name><surname>Dom&#x000ed;nguez-Mart&#x000ed;s</surname><given-names>E.M.</given-names></name><name><surname>L&#x000f3;pez-Ares</surname><given-names>D.</given-names></name><name><surname>Nov&#x000ed;o</surname><given-names>S.</given-names></name></person-group><article-title>Knowledge, Attitudes, and Intentions towards Human Papillomavirus Vaccination among Nursing Students in Spain</article-title><source>Int. J. Environ. Res. Public Health</source><year>2019</year><volume>16</volume><elocation-id>4507</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph16224507</pub-id><pub-id pub-id-type="pmid">31731616</pub-id></element-citation></ref><ref id="B26-vaccines-08-00074"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dany</surname><given-names>M.</given-names></name><name><surname>Chidiac</surname><given-names>A.</given-names></name><name><surname>Nassar</surname><given-names>A.H.</given-names></name></person-group><article-title>Human papillomavirus vaccination: Assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><fpage>1001</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2015.01.009</pub-id><pub-id pub-id-type="pmid">25597945</pub-id></element-citation></ref><ref id="B27-vaccines-08-00074"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelullo</surname><given-names>C.P.</given-names></name><name><surname>Esposito</surname><given-names>M.R.</given-names></name><name><surname>Di Giuseppe</surname><given-names>G.</given-names></name></person-group><article-title>Human Papillomavirus Infection and Vaccination: Knowledge and Attitudes among Nursing Students in Italy</article-title><source>Int. J. Environ. Res. Public Health</source><year>2019</year><volume>16</volume><elocation-id>1770</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph16101770</pub-id><pub-id pub-id-type="pmid">31109133</pub-id></element-citation></ref><ref id="B28-vaccines-08-00074"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genovese</surname><given-names>C.</given-names></name><name><surname>Picerno</surname><given-names>I.A.M.</given-names></name><name><surname>Trimarchi</surname><given-names>G.</given-names></name><name><surname>Cannav&#x000f2;</surname><given-names>G.</given-names></name><name><surname>Egitto</surname><given-names>G.</given-names></name><name><surname>Cosenza</surname><given-names>B.</given-names></name><name><surname>Merlina</surname><given-names>V.</given-names></name><name><surname>Icardi</surname><given-names>G.</given-names></name><name><surname>Panatto</surname><given-names>D.</given-names></name><name><surname>Amicizia</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Vaccination coverage in healthcare workers: A multicenter cross-sectional study in Italy</article-title><source>J. Prev. Med. Hyg.</source><year>2019</year><volume>60</volume><fpage>E12</fpage><lpage>E17</lpage><pub-id pub-id-type="pmid">31041405</pub-id></element-citation></ref><ref id="B29-vaccines-08-00074"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durando</surname><given-names>P.</given-names></name><name><surname>Alicino</surname><given-names>C.</given-names></name><name><surname>Dini</surname><given-names>G.</given-names></name><name><surname>Barberis</surname><given-names>I.</given-names></name><name><surname>Bagnasco</surname><given-names>A.M.</given-names></name><name><surname>Iudici</surname><given-names>R.</given-names></name><name><surname>Zanini</surname><given-names>M.</given-names></name><name><surname>Martini</surname><given-names>M.</given-names></name><name><surname>Toletone</surname><given-names>A.</given-names></name><name><surname>Paganino</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Determinants of adherence to seasonal influenza vaccination among healthcare workers from an Italian region: Results from a cross-sectional study</article-title><source>BMJ Open</source><year>2016</year><volume>6</volume><fpage>e010779</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2015-010779</pub-id><pub-id pub-id-type="pmid">27188810</pub-id></element-citation></ref><ref id="B30-vaccines-08-00074"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attwell</surname><given-names>K.</given-names></name><name><surname>Smith</surname><given-names>D.T.</given-names></name><name><surname>Ward</surname><given-names>P.R.</given-names></name></person-group><article-title>The Unhealthy Other&#x02019;: How vaccine rejecting parents construct the vaccinating mainstream</article-title><source>Vaccine</source><year>2018</year><volume>36</volume><fpage>1621</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2018.01.076</pub-id><pub-id pub-id-type="pmid">29449097</pub-id></element-citation></ref><ref id="B31-vaccines-08-00074"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blake</surname><given-names>K.D.</given-names></name><name><surname>Ottenbacher</surname><given-names>A.J.</given-names></name><name><surname>Finney Rutten</surname><given-names>L.J.</given-names></name><name><surname>Grady</surname><given-names>M.A.</given-names></name><name><surname>Korbrin</surname><given-names>S.C.</given-names></name><name><surname>Jacobson</surname><given-names>R.M.</given-names></name><name><surname>Hesse</surname><given-names>B.W.</given-names></name></person-group><article-title>Predictors of human papillomavirus awareness and knowledge 2013: Gaps and opportunities for targeted communication strategies</article-title><source>Am. J. Prev. Med.</source><year>2015</year><volume>48</volume><fpage>402</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2014.10.024</pub-id><pub-id pub-id-type="pmid">25700651</pub-id></element-citation></ref><ref id="B32-vaccines-08-00074"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>K.R.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name></person-group><article-title>Predictors of Adults&#x02019; Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine</article-title><source>Health Educ. Behav.</source><year>2018</year><volume>45</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1177/1090198117709318</pub-id><pub-id pub-id-type="pmid">28595454</pub-id></element-citation></ref><ref id="B33-vaccines-08-00074"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>S.M.</given-names></name><name><surname>Nailer</surname><given-names>E.</given-names></name><name><surname>Minshall</surname><given-names>C.</given-names></name><name><surname>Coombes</surname><given-names>R.</given-names></name><name><surname>Copper</surname><given-names>J.</given-names></name><name><surname>Redman</surname><given-names>C.W.</given-names></name></person-group><article-title>Awareness and knowledge of HPV and cervical cancer in female students: A survey (with a cautionary note)</article-title><source>J. Obstet. Gynaecol.</source><year>2016</year><volume>36</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.3109/01443615.2015.1041886</pub-id><pub-id pub-id-type="pmid">26408400</pub-id></element-citation></ref><ref id="B34-vaccines-08-00074"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subasinghe</surname><given-names>A.K.</given-names></name><name><surname>Nguyen</surname><given-names>M.</given-names></name><name><surname>Wark</surname><given-names>J.D.</given-names></name><name><surname>Tabrizi</surname><given-names>S.N.</given-names></name><name><surname>Garland</surname><given-names>S.M.</given-names></name></person-group><article-title>Targeted Facebook Advertising is a Novel and Effective Method of Recruiting Participants into a Human Papillomavirus Vaccine Effectiveness Study</article-title><source>JMIR Res. Protoc.</source><year>2016</year><volume>5</volume><fpage>e154</fpage><pub-id pub-id-type="doi">10.2196/resprot.5679</pub-id><pub-id pub-id-type="pmid">27450586</pub-id></element-citation></ref><ref id="B35-vaccines-08-00074"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keelan</surname><given-names>J.</given-names></name><name><surname>Pavri</surname><given-names>V.</given-names></name><name><surname>Balakrishnan</surname><given-names>R.</given-names></name><name><surname>Wilson</surname><given-names>K.</given-names></name></person-group><article-title>An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>1535</fpage><lpage>1540</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.11.060</pub-id><pub-id pub-id-type="pmid">20003922</pub-id></element-citation></ref><ref id="B36-vaccines-08-00074"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amicizia</surname><given-names>D.</given-names></name><name><surname>Domnich</surname><given-names>A.</given-names></name><name><surname>Gasparini</surname><given-names>R.</given-names></name><name><surname>Bragazzi</surname><given-names>N.L.</given-names></name><name><surname>Lai</surname><given-names>P.L.</given-names></name><name><surname>Panatto</surname><given-names>D.</given-names></name></person-group><article-title>An overview of current and potential use of information and communication technologies for immunization promotion among adolescents</article-title><source>Hum Vaccine Immunother.</source><year>2013</year><volume>9</volume><fpage>2634</fpage><lpage>2642</lpage><pub-id pub-id-type="doi">10.4161/hv.26010</pub-id><pub-id pub-id-type="pmid">23954845</pub-id></element-citation></ref><ref id="B37-vaccines-08-00074"><label>37.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>Ministero della Salute</collab></person-group><article-title>Decreto legge 7 giugno 2017, n. 73, Disposizioni Urgenti in Materia di Prevenzione Vaccinale, Come Modificato Dalla Legge di Conversione 31 Luglio. 2017, n. 119</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=60201">http://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=60201</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-01-23">(accessed on 23 January 2020)</date-in-citation></element-citation></ref><ref id="B38-vaccines-08-00074"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>A.M.</given-names></name><name><surname>Do</surname><given-names>T.Q.N.</given-names></name><name><surname>Goodman</surname><given-names>M.</given-names></name><name><surname>Schmeler</surname><given-names>K.M.</given-names></name><name><surname>Kaul</surname><given-names>S.</given-names></name><name><surname>Kuo</surname><given-names>Y.F.</given-names></name></person-group><article-title>Human papillomavirus vaccine interventions in the U.S.: A systematic review and metaanalysis</article-title><source>Am. J. Prev. Med.</source><year>2019</year><volume>56</volume><fpage>591</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2018.10.033</pub-id><pub-id pub-id-type="pmid">30773231</pub-id></element-citation></ref><ref id="B39-vaccines-08-00074"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berenson</surname><given-names>A.B.</given-names></name><name><surname>Hirth</surname><given-names>J.M.</given-names></name><name><surname>Fuchs</surname><given-names>E.L.</given-names></name><name><surname>Chang</surname><given-names>M.</given-names></name><name><surname>Rupp</surname><given-names>R.E.</given-names></name></person-group><article-title>An educational intervention to improve attitudes regarding HPV vaccination and comfort with counseling among US medical students</article-title><source>Hum. Vaccine Immunother.</source><year>2019</year><volume>6</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1080/21645515.2019.1692558</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="vaccines-08-00074-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00074-t001_Table 1</object-id><label>Table 1</label><caption><p>Baseline characteristics of the study&#x02019;s participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>N (%)</italic>
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Median (25&#x02013;75 p)</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">680 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Variables</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (19&#x02013;21)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Sex</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">443 (65.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">237 (34.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Birthplace</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" rowspan="1" colspan="1">652 (95.88)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (0.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Parents&#x02019; nationality</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Italian parents</td><td align="center" valign="middle" rowspan="1" colspan="1">515 (75.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">146 (21.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Educational qualification of parents</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Primary School Certificate</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (0.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Secondary School Certificate</td><td align="center" valign="middle" rowspan="1" colspan="1">153 (29.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">High School Diploma</td><td align="center" valign="middle" rowspan="1" colspan="1">231 (45.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">University Degree</td><td align="center" valign="middle" rowspan="1" colspan="1">125 (24.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">169 (24.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Parents employed</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">507 (74.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">159 (23.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Parents healthcare worker</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">50 (10.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Student</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">660 (97.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (2.94%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>University students</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">597 (90.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Health sciences</td><td align="center" valign="middle" rowspan="1" colspan="1">186 (31.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Other</td><td align="center" valign="middle" rowspan="1" colspan="1">393 (65.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (2.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Worker</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">147 (21.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Economic status</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Acceptable</td><td align="center" valign="middle" rowspan="1" colspan="1">239 (35.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Good</td><td align="center" valign="middle" rowspan="1" colspan="1">364 (53.53)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Poor</td><td align="center" valign="middle" rowspan="1" colspan="1">77 (11.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Diet</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">157 (23.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Physical activity</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">385 (56.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Surf the web</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2 h</td><td align="center" valign="middle" rowspan="1" colspan="1">436 (64.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3&#x02013;4 h</td><td align="center" valign="middle" rowspan="1" colspan="1">184 (27.42)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;5 h</td><td align="center" valign="middle" rowspan="1" colspan="1">51 (7.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Use of social network</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2 h</td><td align="center" valign="middle" rowspan="1" colspan="1">330 (49.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3&#x02013;4 h</td><td align="center" valign="middle" rowspan="1" colspan="1">233 (34.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;5 h</td><td align="center" valign="middle" rowspan="1" colspan="1">103 (15.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Religion</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">449 (66.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Catholics</td><td align="center" valign="middle" rowspan="1" colspan="1">425 (94.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Cohabitants</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Parents</td><td align="center" valign="middle" rowspan="1" colspan="1">580 (85.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Friends</td><td align="center" valign="middle" rowspan="1" colspan="1">60 (8.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alone</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (4.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sexual Partner</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (1.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Sexual Partner</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">420 (61.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Use of contraceptive methods</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">352 (83.81)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Type of contraceptive method</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Condom</td><td align="center" valign="middle" rowspan="1" colspan="1">217 (61.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Oral contraceptive</td><td align="center" valign="middle" rowspan="1" colspan="1">112 (31.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vaginal ring</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (7.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Intrauterine spiral</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (1.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Sexual orientation</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Heterosexual</td><td align="center" valign="middle" rowspan="1" colspan="1">661 (97.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bisexual</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (1.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Homosexual</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (1.47)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Sexual Partners in the last year</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (1&#x02013;1)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Age of first sexual intercourse</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">17 (16&#x02013;18)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Lifetime sexual partners</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (1&#x02013;4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>History of immunodeficiencies</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (2.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>History of STIs</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (4.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>History of HPV related lesions</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 (2.21)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>Frequencies and percentages for categorical variables and median and 25&#x02013;75 percentiles for continuous variables, were calculated. Abbreviations: Non-responded, NR; sexually transmitted infections, STIs.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00074-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00074-t002_Table 2</object-id><label>Table 2</label><caption><p>Sources of information about HPV.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variables</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>N (%)</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ever heard about HPV</td><td align="center" valign="middle" rowspan="1" colspan="1">578 (85.00)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ever heard about HPV vaccine</td><td align="center" valign="middle" rowspan="1" colspan="1">547 (80.44)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Family member</td><td align="center" valign="middle" rowspan="1" colspan="1">239 (43.69)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Internet</td><td align="center" valign="middle" rowspan="1" colspan="1">131 (23.95)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Teacher</td><td align="center" valign="middle" rowspan="1" colspan="1">137 (25.05)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Information from the Local Health Agency</td><td align="center" valign="middle" rowspan="1" colspan="1">129 (23.58)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Healthcare workers of a vaccine center</td><td align="center" valign="middle" rowspan="1" colspan="1">69 (12.61)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pediatrician/General Practitioner</td><td align="center" valign="middle" rowspan="1" colspan="1">101 (18.46)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Radio/TV</td><td align="center" valign="middle" rowspan="1" colspan="1">89 (16.27)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gynecologist</td><td align="center" valign="middle" rowspan="1" colspan="1">78 (14.26)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Newspapers</td><td align="center" valign="middle" rowspan="1" colspan="1">68 (12.43)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Friends</td><td align="center" valign="middle" rowspan="1" colspan="1">59 (10.79)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nurse</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (4.94)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Other specialist doctor</td><td align="center" valign="middle" rowspan="1" colspan="1">21 (3.84)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Other Healthcare professionals</td><td align="center" valign="middle" rowspan="1" colspan="1">21 (3.84)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sexual Partner</td><td align="center" valign="middle" rowspan="1" colspan="1">16 (2.93)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Colleagues</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (1.83)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pharmacist</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (1.10)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Favourite source of information on HPV vaccines</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trusted doctor</td><td align="center" valign="middle" rowspan="1" colspan="1">387 (56.91)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Internet</td><td align="center" valign="middle" rowspan="1" colspan="1">330 (48.53)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Books/paper material</td><td align="center" valign="middle" rowspan="1" colspan="1">105 (15.44)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Friends</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 (3.53)</td></tr></tbody></table><table-wrap-foot><fn><p>Frequencies and percentages for categorical variables and median and 25&#x02013;75 percentiles for continuous variables, were calculated.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00074-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00074-t003_Table 3</object-id><label>Table 3</label><caption><p>Study&#x02019;s participants&#x02019; knowledge about HPV infection, related diseases, and prevention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Knowledge Statement</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Response</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Correct</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Do not Know</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Wrong</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>N</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>N</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>N</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV infection is transmitted through sexual intercourse</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">560</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.68</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">If yes, early sexual debut increases the risk of contracting HPV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">263</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">170</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.36</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">If yes, using condoms reduces the risk of HPV transmission</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">481</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.12</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">If yes, a high number of sexual partners increases the risk of contracting HPV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">383</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.28</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV infection can be transmitted from mother to child during pregnancy and during delivery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">274</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">292</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">114</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.77</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV can infect both males and females</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">527</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">153</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.50</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disease associated with HPV in men: penile cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">114</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">221</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">198</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.14</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disease associated with HPV in women: cervical cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">367</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">172</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">141</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.74</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV can lead to genital warts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">291</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">334</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">If yes, genital warts affect both male and female</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">234</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.58</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV infection is widespread</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">358</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.65</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">246</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.17</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Most HPV infected people develop cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">False</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">118</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">278</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">284</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.76</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV infection can be transmitted from a carrier to his/her partner only if the carrier shows symptoms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">False</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">331</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">207</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">142</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.88</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A person may be HPV-infected and not be aware of it</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">452</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">180</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.06</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">There are no specific therapies for HPV infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">159</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">319</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">202</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.71</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Both males and females can be vaccinated against HPV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">461</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">216</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.76</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The HPV vaccine is also effective in after starting sexual activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">400</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">199</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.91</td></tr></tbody></table><table-wrap-foot><fn><p>For each knowledge statement, the correct answer is reported. Frequencies and percentages of correct, wrong and unknown answers were calculated.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00074-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00074-t004_Table 4</object-id><label>Table 4</label><caption><p>Participants&#x02019; knowledge and attitude scores stratified by their characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Characteristics</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Knowledge Score</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
<italic>p-Value</italic>
</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Attitude Score</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
<italic>p-Value</italic>
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Median (25&#x02013;75 p)</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Median (25&#x02013;75 p)</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Sex</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.7976</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0053</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (38.5&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Birthplace</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0716</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.7724</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other Countries</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.35 (32.8&#x02013;64.08)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Parents&#x02019; nationality</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0492</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italian</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (37.5&#x02013;64.7)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5907</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 (33.3&#x02013;62.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Educational qualification of parents</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.6626</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.6358</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary School Certificate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.85 (25&#x02013;64.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Secondary School Certificate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.9 (38&#x02013;62.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High School Diploma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (38.5&#x02013;66.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">University Degree</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Parents employed</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (37.5&#x02013;64.7)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.9090</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.3643</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 (42.85&#x02013;63.05)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;4.13)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Parents healthcare worker</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.15 (35.1&#x02013;73.73)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.1899</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;4.5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0103</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (37.5&#x02013;62.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>University students</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x0003c;0.0001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.2365</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health sciences</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5 (50&#x02013;80)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.7 (34.3&#x02013;60)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Worker</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (40&#x02013;68.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.7846</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0211</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Economic status</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.3755</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acceptable</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (38.5&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0031</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Good</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (37.5&#x02013;62.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;4.5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Diet</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (38.75&#x02013;66.7)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.6699</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;4.75)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Physical activity</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.3145</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0577</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (39.63&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Surf the web</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.9326</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4214</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;2 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x02013;4 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;5 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (40&#x02013;64.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Use of social network</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0215</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0115</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;2 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (42.9&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x02013;4 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (38.5&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;5 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (33.3&#x02013;62.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;4.5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Religion</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (40&#x02013;68.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4945</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.9570</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (37.5&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Cohabitants</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5603</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4981</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parents</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;66.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Friends</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.1 (31.8&#x02013;76.13)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.6 (32.85&#x02013;82.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sexual Partner</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.75 (33.3&#x02013;64.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;4.5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Sexual Partner</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5538</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.8926</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Contraceptive methods used</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.55 (40&#x02013;66.7)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.8904</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5055</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (35.7&#x02013;73.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Sexual orientation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.3461</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0841</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heterosexual</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3(40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bisexual</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.9 (36.5&#x02013;59.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homosexual</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.8 (35.95&#x02013;88.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.75 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Sexual Partners in the last year</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5801</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.1398</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0&#x02013;2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265; 3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.9 (38.75&#x02013;69.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Age of first sexual intercourse</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4739</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4767</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13&#x02013;14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.8 (35.1&#x02013;65.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15&#x02013;17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3 (38.25&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265; 18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (41.7&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Lifetime sexual partners</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.1491</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.1929</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0&#x02013;3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (38.5&#x02013;68.28)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>History of immunodeficiency</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (38.5&#x02013;63.05)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.7165</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (3.88&#x02013;4.13)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0381</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>History of STIs</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5 (41.7&#x02013;78.9)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0349</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.1241</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>History of HPV related lesions</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.8 (46.2&#x02013;88.2)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0290</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4276</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Ever heard about HPV</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0035</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.7 (33.3&#x02013;62.95)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (3.5&#x02013;4.3)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Ever heard about HPV vaccine</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (41.7&#x02013;68.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 (34.5&#x02013;62.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (3.75&#x02013;4.5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Source of information on HPV vaccine</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Family member</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;66.7)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0501</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.6436</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.95 (42.9&#x02013;73.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Internet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.8 (42.9&#x02013;73.3)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.2843</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.8713</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40.43&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Teacher</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 (43.8&#x02013;72.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0773</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0100</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Information from the Local Health Agency</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.8 (46.2&#x02013;70.6)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.1671</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthcare workers of a vaccine center</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (43.8&#x02013;62.5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.2754</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.6951</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (41.27&#x02013;70.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pediatrician/General Practitioner</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (43.8&#x02013;68.8)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.6522</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0061</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Radio/TV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.8 (33.3&#x02013;65.7)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0762</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4692</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (43.57&#x02013;70.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gynecologist</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5 (46.7&#x02013;81.57)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0564</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Newspapers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (35.4&#x02013;70.15)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.7765</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.3178</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (42.9&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Friends</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.1 (43.8&#x02013;66.7)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5906</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4726</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 (40&#x02013;68.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 (4&#x02013;5)</td></tr></tbody></table><table-wrap-foot><fn><p>For each knowledge statement, one point was given for a correct answer (true or false) and zero points if a wrong answer or &#x0201c;Do not know&#x0201d; was reported. The knowledge score is the number of correct answers/number of knowledge statements &#x000d7; 100. Attitude score of each subject was estimated through a five-point Likert scale (5 points&#x02014;Strongly Agree, 4 point-Agree, 3 points-Neutral, 2 points-Disagree, 1 points-Strongly Disagree) and is the median of the total points was calculated for every participant (range =1.0 to 5.0). The univariable logistic regression tested the possible association of baseline characteristics of young adults with knowledge and attitude scores. A <italic>p</italic>-value less than 0.05 was considered significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00074-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00074-t005_Table 5</object-id><label>Table 5</label><caption><p>Study&#x02019;s participants&#x02019; attitudes toward HPV infections, related diseases, and prevention statements.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Attitude Statement</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Strongly Agree</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Agree</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Neutral</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Disagree</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Strongly Disagree</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>%</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe that Papillomavirus (HPV) can cause serious diseases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">380</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">258</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.74</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe that I will be exposed to HPV infection during my life</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">261</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">225</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.12</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe anti-HPV vaccines are capable of preventing the occurrence of cervical cancer and genital warts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">338</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">280</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe the anti-HPV vaccination must be mandatory for boys and girls before the sexual debut and for at risk subjects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">332</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">238</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.48</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe my parents&#x02019; favorable opinion is essential to decide to get vaccinated against HPV *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">114</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.57</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">204</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">169</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.16</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe that the favorable opinion of my partner is essential to decide to get vaccinated against HPV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">194</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">175</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">106</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.59</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe it is useful to talk to my doctor about HPV infections and other sexually transmitted infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">243</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">337</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.73</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe it is useful to talk about HPV infections and other sexually transmitted infections at school</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">364</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">251</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.29</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe if I have children I get them vaccinated against HPV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">324</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.65</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">244</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">102</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I believe the anti-HPV vaccine is safe</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">218</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">302</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">139</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.59</td></tr></tbody></table><table-wrap-foot><fn><p>Legend: * N. 66 (9.71%) subjects did not answer. For each attitude statement, the answer is reported. Frequencies and percentages of &#x0201c;strongly agree&#x0201d;, &#x0201c;agree&#x0201d;, &#x0201c;neutral&#x0201d;, &#x0201c;disagree&#x0201d;, &#x0201c;strongly disagree&#x0201d; answers were calculated.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00074-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00074-t006_Table 6</object-id><label>Table 6</label><caption><p>Multivariate analysis for predicting knowledge score.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristics</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-Coefficient (95% C.I.)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">95% C.I. Lower Limit</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">95% C.I. Upper Limit</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">University: health sciences</td><td align="center" valign="middle" rowspan="1" colspan="1">6.713</td><td align="center" valign="middle" rowspan="1" colspan="1">4.508</td><td align="center" valign="middle" rowspan="1" colspan="1">8.918</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Use of social network &#x02264;2 h/day</td><td align="center" valign="middle" rowspan="1" colspan="1">2.691</td><td align="center" valign="middle" rowspan="1" colspan="1">0.547</td><td align="center" valign="middle" rowspan="1" colspan="1">4.834</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0141</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">History of STIs</td><td align="center" valign="middle" rowspan="1" colspan="1">4.208</td><td align="center" valign="middle" rowspan="1" colspan="1">0.114</td><td align="center" valign="middle" rowspan="1" colspan="1">8.302</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0440</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ever heard about HPV</td><td align="center" valign="middle" rowspan="1" colspan="1">8.789</td><td align="center" valign="middle" rowspan="1" colspan="1">2.397</td><td align="center" valign="middle" rowspan="1" colspan="1">15.181</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0072</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ever heard about HPV vaccine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.061</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.262</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.859</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0135</td></tr></tbody></table><table-wrap-foot><fn><p>Covariates significant at 0.1 in the univariate analysis were evaluated for inclusion in multivariable regression model, using a backward stepwise algorithm.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00074-t007" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00074-t007_Table 7</object-id><label>Table 7</label><caption><p>Multivariate analysis for predicting attitude score.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristics</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-Coefficient (95% C.I.)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">95% C.I. Lower Limit</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">95% C.I. Upper Limit</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Italian parents</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.1548</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.3031</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.0065</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0408</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Worker</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.0911</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.1610</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.0213</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0106</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Economic status: good</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0713</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0178</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1246</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0089</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diet</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.1473</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.2126</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.0821</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ever heard about HPV</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1715</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1018</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2413</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parents healthcare worker</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.1132</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.2001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.0263</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0108</td></tr></tbody></table><table-wrap-foot><fn><p>Covariates that were significant at 0.1 in the univariate analysis were evaluated for inclusion in multivariable regression model, using a backward stepwise algorithm.</p></fn></table-wrap-foot></table-wrap></floats-group></article>